175865-60-8 (缬更昔洛韦,(2S)-2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)-3-hydroxypropyl 2-amino-3-methylbutanoate)

缬更昔洛韦;(S)-2-氨基-3-甲基丁酸 (R,S)-2-[(2-氨基-6-氧代-1,6-二氢-9H-嘌呤-9-基)甲氧基]-3-羟基丙酯;1-苯基-5-三氟甲基吡唑-4-酰氯;缬-D5盐酸(diastetromers混合物);缬-D8(非对映体混合物);缬更昔洛韦盐酸;盐酸缬更昔洛韦-D5;

(2S)-2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)-3-hydroxypropyl 2-amino-3-methylbutanoate;Valgancyclovir;5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7- dihydro-3H-imidazo[4,5-d]pyrimidin-7-one;Valganciclovir;L-Valine;Valganciclovir-d8;Valganciclovir-d8 (Mixture of Diastereomers);Valganciclovir & Valganciclovir Hydrochloride;Valganciclovir-d5 HCl (Mixture of diastetroMers);2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate;5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one;L-Valine, 2-((2-amino-3,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester;NCGC00387997-04;NS00000462;[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxy-propyl] (2S)-2-amino-3-methyl-butanoate;AKOS015966553;Cymeval;HSDB 8085;GTPL4716;[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;valganciclovirum;L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester;2-((2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy)-3-hydroxypropyl L-valinate;Valganciclovir [INN:BAN];J05AB14;SCHEMBL28996;NCGC00387997-02;BRD-A50922295-003-01-9;RS 79070;ganciclovir L-valyl ester;Valganciclovir (INN);L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester;AM807983;DTXCID3028263;HY-A0032;Ro-1079070/194;CHEBI:63635;L-Valine, ester with ganciclovir;SCHEMBL12672612;GCU97FKN3R;AKOS015896083;AB01563009_01;Q423384;SCHEMBL22357189;175865-60-8;CS-0950;DTXSID8048288;EN300-37158611;L-VALINE, ESTER WITH 9-((2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY)METHYL)GUANINE;DB01610;2-[(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl L-valinate;CHEMBL1201314;RO1079070/194;D02495;Ganciclovir L valyl Ester;NCGC00168779-01;UNII-GCU97FKN3R;VALGANCICLOVIR [WHO-DD];BRD-A50922295-003-05-0;BRD-A50922295-001-01-3;2-[(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate hydrochloride;VALGANCICLOVIR [MI];2-[(2-AMINO-6-OXO-1H-PURIN-9-YL)METHOXY]-3-HYDROXYPROPYL (2S)-2-AMINO-3-METHYLBUTANOATE;VALGANCICLOVIR [INN];VALGANCICLOVIR [VANDF];DA-58945;

MFCD08460118

WPVFJKSGQUFQAP-GKAPJAKFSA-N

1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1

O(CN1C=NC2C(NC(N)=NC1=2)=O)C(CO)COC([C@H](C(C)C)N)=O

2933990090